We are looking for prescription products in women's health, cardiology, diabetes, and products used by family practitioners and internists for sale in the US which are promotion-sensitive and are either not sold in the US or are not actively marketed

Our foremost interest is in woman's health, cardiology, diabetes, and products used by family practitioners and internists. We may also be interested in products prescribed by other niche physician categories.

Our strategy is to acquire or in-license prescription pharmaceutical products for sale in the United States and/or outside of the US which are promotion-sensitive and which are:

• In phase III (and perhaps phase II) of development

• Successful (or becoming successful) outside of the United States but which are not yet available in the United States; and

Further, we may also acquire companies with products and / or development pipelines consistent with the above. Finally, we intend to develop new patentable formulations, use new delivery methods and seek regulatory approval for new indications of existing drugs in furtherance of our life cycle strategies.

Phase II

We are open to all different types of deals ranging from distribution in a country to acquisitions. We are mainly interested in bringing products to the US.